solid tumors News
Latest articles and news about solid tumors on AXL Media.
Latest Articles
- Natural Compound Timosaponin AIII Breakthrough Enhances CAR-T Efficacy and Overcomes Immunotherapy Resistance in Solid Tumors
Published: Apr 30, 2026
Section: Research
A collaborative research team in China has identified Timosaponin AIII as a potent natural immunomodulator that selectively eliminates suppressive CAR-T regulatory cells. By blocki...
- Metabolic Rewiring Emerges as Key Strategy to Help CAR-T Cells Survive and Destroy Solid Tumors
Published: Apr 30, 2026
Section: Health Technology
Researchers are developing "metabolic reprogramming" techniques to help CAR-T cell therapies overcome the nutrient-deprived and toxic environments of solid tumors. By genetically a...
- Next-Generation CAR T-Cell Therapies Shift Toward Multifunctional “Living Drugs” to Tackle Solid Tumors
Published: Apr 30, 2026
Section: Health Technology
A comprehensive review of over 1,800 clinical trials reveals that CAR T-cell therapy is evolving from single-target designs into complex, multifunctional systems. These "next-gener...
- Biomedical Engineering Breakthroughs Repurpose CAR-T Cell Therapy to Target Autoimmune Disorders and Chronic Viruses
Published: Apr 29, 2026
Section: Medical News
A landmark review published in Frontiers in Immunology on April 29, 2026, details the strategic evolution of Chimeric Antigen Receptor (CAR) T-cell therapy beyond its traditional r...
- LabMed Discovery Youth Scholars Salon To Tackle Neoadjuvant Immunotherapy And Solid Tumor Biomarkers In Sixth Global Academic Forum
Published: Apr 25, 2026
Section: Health
The editorial team of LabMed Discovery has announced its sixth Youth Scholars Salon, a live-streamed academic event focusing on cutting-edge oncological treatments. The forum will...
- Penn Medicine Reports First Clinical Safety Data for Multi-Chain KIR-CAR T Therapy Targeting Advanced Solid Tumors
Published: Apr 21, 2026
Section: Medical News
Researchers at the University of Pennsylvania have shared promising early results from the STAR-101 Phase I clinical trial, demonstrating that a novel "KIR-CAR" T cell therapy is s...
- University of Pennsylvania Study Shows Lipid Nanoparticles Successfully Engineer CAR T Cells In Vivo to Dissolve Pancreatic Tumor Barriers
Published: Apr 1, 2026
Section: Health Technology
Researchers at the University of Pennsylvania have utilized lipid nanoparticles to program immune cells directly inside the body to target the dense connective tissue shielding pan...
- Penn Vet Researchers Use Lipid Nanoparticles To "Melt Away" Pancreatic Cancer’s Protective Barrier And Enhance CAR T-Cell Success In Solid Tumors
Published: Mar 31, 2026
Section: Research
A breakthrough study led by the University of Pennsylvania has demonstrated that lipid nanoparticles can generate CAR T cells inside the body to target tumor-supporting cells. By e...
- Dual-Action CAR T Cell Therapy Successfully Targets Both Solid Tumors and the Protective "Eco-System" that Shield Them
Published: Mar 31, 2026
Section: Research
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have engineered a new type of CAR T cell that targets the protein uPAR, found on both aggressive cancer cells and the su...
- Stanford Medicine Engineers Immune Cells with Metabolite Sensors to Track and Eradicate Aggressive Solid Tumors
Published: Mar 25, 2026
Section: Health
Researchers at Stanford Medicine have developed a novel immunotherapy that equips natural killer and T cells with receptors to detect metabolic byproducts released by solid tumors....
- UCLA Engineers Develop Implantable "Charging Station" to Sustain Immune Cell Attacks on Solid Tumors
Published: Mar 18, 2026
Section: Science & Tech
Researchers at UCLA have created a biomimetic implantable device designed to recharge and reactivate engineered immune cells within the suppressive environment of a tumor. By provi...
- University of Pennsylvania Engineers Develop Universal Nanoparticle Therapy to Reinvigorate Exhausted T Cells in Solid Tumors
Published: Mar 18, 2026
Section: Science & Tech
Researchers at the University of Pennsylvania have engineered a dual-function lipid nanoparticle (LNP) that simultaneously blocks immune-suppressing enzymes and delivers protein-co...